Author Details

Жукова, Л Г

Issue Section Title File
Vol 11, No 1 (2009) Articles Bevatsizumab (Avastin) v kombinatsii s taksanami v 1-y linii lecheniya HER-2-negativnogo metastaticheskogo raka molochnoy zhelezy(Rezul'taty issledovaniya AVADO)
Vol 11, No 1 (2009) Articles Dlitel'noe i bezopasnoe primenenie Avastina pri metastaticheskom kolorektal'nom rake: klinicheskiy opyt primeneniya
Vol 11, No 3 (2009) Articles Klinicheskaya effektivnost'i bezopasnost' primeneniya otechestvennogo rekombinantnogo granulotsitarnogo koloniestimuliruyushchego faktora Neypomaks® u bol'nykh rakom molochnoy zhelezy, poluchayushchikh khimioterapiyu doksorubitsinom i dotsetakselom
Vol 12, No 1 (2010) Articles Sovremennye aspektyprofilaktiki neytropeniipri khimioterapii solidnykh opukholey
Vol 12, No 3 (2010) Articles Bevatsizumab v lechenii HER2-negativnogometastaticheskogo raka molochnoy zhelezy:sovremennye dannye ob effektivnostii bezopasnosti
Vol 13, No 2 (2011) Articles Klinicheskie rekomendatsii po profilaktikei lecheniyu toshnoty i rvoty u bol'nykh,poluchayushchikh khimio- i luchevuyuprotivoopukholevuyu terapiyu
Vol 17, No 1 (2015) Articles The improvement in overall survival for patients with metastatic breast cancer treated with eribulin: the resolution based on results of the expert council
Vol 18, No 2 (2016) Articles Development of cytotoxic chemotherapy in metastatic breast cancer with a triple-negative phenotype PDF
(Rus)
Vol 13, No 1 (2011) Articles Opyt dlitel'nogo primeneniya kombinatsii kapetsitabina, lapatiniba i trastuzumabapri HER-2-pozitivnom metastaticheskom rake molochnoy zhelezy. Opisanie klinicheskogo sluchaya
Vol 13, No 4 (2011) Articles Antiangiogennaya terapiyapri rake molochnoy zhelezys troynym negativnym fenotipom

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies